Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer Consumer Health Journey Still Short Of Destination

Executive Summary

Bayer says issues encountered after acquiring Merck & Co.’s consumer brands two years ago have meant slower growth than expected. But it suggests that’s not a precedent for its planned mega-merger with Monsanto.

Advertisement

Related Content

Bayer ‘All Hands On Deck’ For US Consumer Business Turnaround
Bayer ‘All Hands On Deck’ For US Consumer Business Turnaround
Bayer Plans 19 Consumer Product Launches To Revive Sluggish Sales
Bayer Plans 19 Consumer Product Launches To Revive Sluggish Sales
Nonprescription Nasonex Gains UK Regulator’s Support
Nonprescription Nasonex Gains UK Regulator’s Support
Bayer Reiterates Pharma Commitment Post-Monsanto, Plays Up Pipeline
Bayer's ClariSpray Brings Hint Of Familiar Brand To Nasal Allergy Space
Bayer Leveraging Consumer Growth From Product Launches, More Shelf Space
Oxytrol For Women Exclusivity Ends Not With Competition, But Label Warning Change

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS119398

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel